G

M

GION , M.

Last name: GION

First name: M.

October 6, 2023 (v1)

Publication

Metadata-only

Pembrolizumab in combination with gemcitabine for patients with HER2-negative advanced breast cancer: GEICAM/2015–04 (PANGEA-Breast) study

Cruz Merino, Luis de la Gion, M. Cruz, J.

Background: We evaluated a new chemoimmunotherapy combination based on the anti-PD1 monoclonal antibody pembrolizumab and the pyrimidine antimetabolite gemcitabine in HER2- advanced breast cancer (ABC) patients previously treated in the advanced setting, in order to explore a potential synergism that could eventually obtain long term beneft in...

Uploaded on: October 11, 2023